Mark Ratain to Anthracenes
This is a "connection" page, showing publications Mark Ratain has written about Anthracenes.
Connection Strength
0.025
-
Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion. Cancer Chemother Pharmacol. 1993; 31(4):283-8.
Score: 0.025